The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia

Status Completed

Clinical Trial Summary

72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded and used for evaluation of treatment.

Clinical Trial Description

To test the effect of Chinese herb against the hypertensive heart disease, we designed this randomized controlled clinical trial. 72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. 2 weeks after treatment, all the symptoms were graded again. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04505228
Study type	Interventional
Source	Macrohard Institute of Health
Contact
Status	Completed
Phase	N/A
Start date	January 20, 2020
Completion date	June 20, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03100812` - Asian American Partnerships in Research and Empowerment (AsPIRE)	N/A
Terminated	`NCT01942395` - Dietary Approaches to Stop Hypertension in 'Diastolic' Heart Failure 2 (DASH-DHF 2)	N/A
Completed	`NCT04495231` - Sympathetic Activity and Cardiometabolic Complications
Completed	`NCT01185067` - Physiological Effects of Grape Seed Extract in Diastolic Heart Failure	Phase 1
Enrolling by invitation	`NCT04190420` - The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
Completed	`NCT01990911` - Renal Sympathetic Denervation Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study	N/A
Recruiting	`NCT04830696` - 3D ECG for Detection of Cardiomyopathy
Completed	`NCT00939640` - Effects of the Dietary Approaches to Stop Hypertension(DASH) Sodium-restricted Diet in Diastolic Heart Failure	N/A
Completed	`NCT03271385` - Differentiation HHD From HCM (EARLY-MYO-HHD)
Recruiting	`NCT06186102` - Polyamine Treatment in Elderly Patients With Coronary Artery Disease	Phase 2
Not yet recruiting	`NCT05994729` - Impact of Renal Denervation in Patients With Coronary Microvascular Dysfunction: Study Design and Rationale	N/A
Completed	`NCT05226416` - Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection
Active, not recruiting	`NCT02809040` - E_Stethoscope: Portable Digital Auscultation Study on Hypertensive/Hypertensive Heart Disease Patients	N/A
Recruiting	`NCT00517322` - Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan	Phase 4
Recruiting	`NCT03553810` - Role of ARNi in Ventricular Remodeling in Hypertensive LVH	Phase 2